tirzepatide boston Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Boston, USA. 16th Nov, 2025.

This warning stems from animal studies showing thyroid C-cell tumors in rodents exposed to GLP-1 receptor agonists

Without professional guidance to protect lean muscle mass, we risk trading one metabolic issue for another

Management should be individualized based on risk factors for delayed gastric emptying, with strategies such as a 24-hour liquid diet before surgery for higher-risk patients rather than a blanket recommendation to discontinue the medication

The trial data is the strongest evidence available for understanding how these medications perform

Perceived hunger score at baseline was 4.6 0.8

Do not accept the medication if it has been opened or the seal is broken